Page last updated: 2024-09-04

edotreotide and Carcinoma, Papillary

edotreotide has been researched along with Carcinoma, Papillary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andreas, J; Bockisch, A; Brandt-Mainz, K; Bruns, C; Görges, R; Kahaly, G; Mäcke, H; Müller-Brand, J; Walgenbach, S	1

Other Studies

1 other study(ies) available for edotreotide and Carcinoma, Papillary

Article	Year
[Somatostatin receptor status in non-medullary thyroid carcinoma]. Nuklearmedizin. Nuclear medicine, 1999, Volume: 38, Issue:1 Topics: Adenocarcinoma, Follicular; Adult; Aged; Autoradiography; Carcinoma, Papillary; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed; Yttrium Radioisotopes	1999

Article

Year

[Somatostatin receptor status in non-medullary thyroid carcinoma].

Nuklearmedizin. Nuclear medicine, 1999, Volume: 38, Issue:1

Topics: Adenocarcinoma, Follicular; Adult; Aged; Autoradiography; Carcinoma, Papillary; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed; Yttrium Radioisotopes

1999